Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | thioridazine | 5452 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | thioridazine | 5452 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | thioridazine | 5452 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | thioridazine | 5452 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | thioridazine | 5452 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | thioridazine | 5452 | drug-path |
Proteasome | R-HSA-68819 | map03050 | thioridazine | 5452 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | thioridazine | 5452 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | thioridazine | 5452 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | thioridazine | 5452 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | thioridazine | 5452 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | thioridazine | 5452 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | methapyrilene | 3639 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | methapyrilene | 3639 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | methapyrilene | 3639 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | methapyrilene | 3639 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | methapyrilene | 3639 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | methapyrilene | 3639 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | PHA-00745360 | None | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | PHA-00745360 | None | drug-path |